Risultati della ricerca - Nashat Gabrail

Raffina i risultati
  1. 1
    Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial

    Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial di Adrian S. Dobs, Ralph V. Boccia, C. Croot, Nashat Gabrail, James T. Dalton, Michael L. Hancock, Mary Ann Johnston, Mitchell S. Steiner

    Pubblicazione 2013
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  2. 2
    A phase 2 randomized dose-ranging study of the JAK2-selective inhibitor fedratinib (SAR302503) in patients with myelofibrosis

    A phase 2 randomized dose-ranging study of the JAK2-selective inhibitor fedratinib (SAR302503) in patients with myelofibrosis di Animesh Pardanani, Ayalew Tefferi, Catriona Jamieson, Nashat Gabrail, Claudia Lebedinsky, Guozhi Gao, F Liu, Christine Xu, Hongcui Cao, Moshe Talpaz

    Pubblicazione 2015
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  3. 3
    Randomized Open-Label Phase II Study of Decitabine in Patients With Low- or Intermediate-Risk Myelodysplastic Syndromes

    Randomized Open-Label Phase II Study of Decitabine in Patients With Low- or Intermediate-Risk Myelodysplastic Syndromes di Guillermo Garcia‐Manero, Elias Jabbour, Gautam Borthakur, Stefan Faderl, Zeev Estrov, Hui Yang, Sirisha Maddipoti, Lucy A. Godley, Nashat Gabrail, Jesús G. Berdeja, Ahmed Nadeem, Laurent Kassalow, Hagop Kantarjian

    Pubblicazione 2013
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  4. 4
    Safety and efficacy of copanlisib in combination with nivolumab: a Phase Ib study in patients with advanced solid tumors

    Safety and efficacy of copanlisib in combination with nivolumab: a Phase Ib study in patients with advanced solid tumors di Benedito A. Carneiro, Robert M. Jotte, Nashat Gabrail, Kristopher Wentzel, Funan Huang, Shalini Chaturvedi, Anke Weispfenning, Florian Hiemeyer, Peter N. Morcos, Lidia Mongay Soler, Barrett H. Childs, Aaron R. Hansen

    Pubblicazione 2025
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  5. 5
    Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studies

    Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based... di H. Raftopoulos, Abderrahmane Laadem, Paul J. Hesketh, Jerome H. Goldschmidt, Nashat Gabrail, Cynthia R. Osborne, Muhammad Ali, Matthew L. Sherman, Ding Wang, John A. Glaspy, Marie Puccio-Pick, Jun Zou, Jeffrey Crawford

    Pubblicazione 2015
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  6. 6
    Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer

    Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer di Charu Aggarwal, Neal J. Meropol, Cornelis J.A. Punt, Nicholas Iannotti, Bruce Saidman, Kert D. Sabbath, Nashat Gabrail, Joel Picus, Michael A. Morse, Edith P. Mitchell, Michael Craig Miller, Steven J. Cohen

    Pubblicazione 2012
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  7. 7
    Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer

    Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer di Steven J. Cohen, Cornelis J.A. Punt, Nicholas Iannotti, Bruce Saidman, Kert D. Sabbath, Nashat Gabrail, Joel Picus, Michael Morse, Edith P. Mitchell, Michael Craig Miller, Gerald V. Doyle, H. Tissing, Leon W.M.M. Terstappen, Neal J. Meropol

    Pubblicazione 2008
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  8. 8
    A Multicenter, Phase 2 Study of Vascular Endothelial Growth Factor Trap (Aflibercept) in Platinum- and Erlotinib-Resistant Adenocarcinoma of the Lung

    A Multicenter, Phase 2 Study of Vascular Endothelial Growth Factor Trap (Aflibercept) in Platinum- and Erlotinib-Resistant Adenocarcinoma of the Lung di Natasha B. Leighl, Luis E. Raez, Benjamin Besse, Peter J. Rosen, Fabrice Barlési, Erminia Massarelli, Nashat Gabrail, Lowell L. Hart, Kathy S. Albain, Lloyd Berkowitz, O.O. Melnyk, Frances A. Shepherd, Lars Sternås, Judie Ackerman, Zhenming Shun, Vincent A. Miller, Roy S. Herbst

    Pubblicazione 2010
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  9. 9
    A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors

    A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors di Florence Atrafi, Harry J.M. Groen, Lauren A. Byers, Elena Garralda, Martijn P. Lolkema, Randeep Sangha, Santiago Viteri, Young Kwang Chae, D. Ross Camidge, Nashat Gabrail, Beibei Hu, Tian Tian, Silpa Nuthalapati, Elizabeth Hoening, Lei He, Philip Komarnitsky, Antonio Calles

    Pubblicazione 2018
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  10. 10
    A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia

    A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia di Ramiro Garzon, Michael R. Savona, Rachid Baz, Michael Andreeff, Nashat Gabrail, Martin Gutierrez, Lynn Savoie, Morten Mau‐Sørensen, Nina Wagner‐Johnston, Karen Yee, Thaddeus J. Unger, Jean-Richard Saint-Martin, Robert Carlson, Tami Rashal, Trinayan Kashyap, Boris Klebanov, Sharon Shacham, Michael Kauffman, Richard M. Stone

    Pubblicazione 2017
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  11. 11
    Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom macroglobulinemia

    Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom macroglobulinemia di Christine Chen, David S. Siegel, Martin Gutierrez, Meagan A. Jacoby, Craig C. Hofmeister, Nashat Gabrail, Rachid Baz, Morten Mau‐Sørensen, Jesús G. Berdeja, Michael R. Savona, Lynn Savoie, Suzanne Trudel, Nuchanan Areethamsirikul, Thaddeus J. Unger, Tami Rashal, Tim Hanke, Michael Kauffman, Sharon Shacham, Donna Reece

    Pubblicazione 2017
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  12. 12
    First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors

    First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors di Albiruni R. Abdul Razak, Morten Mau‐Sørensen, Nashat Gabrail, John F. Gerecitano, Anthony F. Shields, Thaddeus J. Unger, Jean Richard Saint-Martin, Robert Carlson, Yosef Landesman, Dilara McCauley, Tami Rashal, Ulrik Lassen, Richard Kim, Lee-Anne Stayner, Mansoor Raza Mirza, Michael Kauffman, Sharon Shacham, Amit Mahipal

    Pubblicazione 2016
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  13. 13
    A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab

    A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab di Joseph Mıkhael, Karim Belhadj‐Merzoug, Cyrille Hulin, Laure Vincent, Philippe Moreau, Cristina Gasparetto, Luděk Pour, Ivan Špıčka, Ravi Vij, Jeffrey A. Zonder, Djordje Atanackovic, Nashat Gabrail, Thomas G. Martin, Aurore Perrot, Samira Bensfia, Qilong Weng, Claire Brillac, Dorothée Sémiond, Sandrine Macé, Kathryn P. Corzo, Xavier Leleu

    Pubblicazione 2021
    Testo Testo
    Carta
    Aggiungi alla lista
    Salvato in:
  14. 14
    Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma

    Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma di John Kuruvilla, Michael R. Savona, Rachid Baz, Morten Mau‐Sørensen, Nashat Gabrail, Ramiro Garzon, Richard M. Stone, Michael Wang, Lynn Savoie, Peter Martin, Ian W. Flinn, Meagan A. Jacoby, Thaddeus J. Unger, Jean-Richard Saint-Martin, Tami Rashal, Sharon Friedlander, Robert Carlson, Michael Kauffman, Sharon Shacham, Martin Gutierrez

    Pubblicazione 2017
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  15. 15
    Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trial

    Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trial di Jennifer R. Brown, Mehdi Hamadani, John Hayslip, Ann Janssens, Nina D. Wagner‐Johnston, Oliver G. Ottmann, Jon Arnason, Hervé Tilly, Michael Millenson, Fritz Offner, Nashat Gabrail, Siddhartha Ganguly, Sikander Ailawadhi, Siddha Kasar, Arnon P. Kater, Jeanette K. Doorduijn, Lei Gao, Joanne Lager, Bin Wu, Coumaran Égile, Marie José Kersten

    Pubblicazione 2018
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  16. 16
    An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma

    An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma di Ravi Vij, Michael Wang, Jonathan L. Kaufman, Sagar Lonial, Andrzej Jakubowiak, A. Keith Stewart, Vishal Kukreti, Sundar Jagannath, Kevin T. McDonagh, Melissa Alsina, Nizar J. Bahlis, Frederic J. Reu, Nashat Gabrail, Andrew R. Belch, Jeffrey Matous, Peter P. Lee, Peter J. Rosen, Michaël Sébag, David H. Vesole, Lori Kunkel, Sandra Wear, Alvin Wong, Robert Z. Orlowski, David S. Siegel

    Pubblicazione 2012
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  17. 17
    Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti–PD-1 Refractory Melanoma

    Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti–PD-1 Refractory Melanoma di Cara Haymaker, Daniel H. Johnson, Ravi Murthy, Salah-Eddine Bentebibel, Marc Uemura, Courtney W. Hudgens, Houssein Safa, Marihella James, Robert H.I. Andtbacka, Douglas B. Johnson, Montaser Shaheen, Michael A. Davies, Shah Rahimian, Srinivas K. Chunduru, Denái R. Milton, Michael T. Tetzlaff, Willem W. Overwijk, Patrick Hwu, Nashat Gabrail, Sudhir Agrawal, Gary C. Doolittle, Igor Puzanov, Joseph Markowitz, Chantale Bernatchez, Adi Diab

    Pubblicazione 2021
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  18. 18
    Pharmacokinetic Exposure Equivalence and Preliminary Efficacy and Safety from a Randomized Cross over Phase 3 Study (ASCERTAIN study) of an Oral Hypomethylating Agent ASTX727 (cedazuridine/decitabine) Compared to IV Decitabine

    Pharmacokinetic Exposure Equivalence and Preliminary Efficacy and Safety from a Randomized Cross over Phase 3 Study (ASCERTAIN study) of an Oral Hypomethylating Agent ASTX727 (ceda... di Guillermo Garcia‐Manero, James McCloskey, Elizabeth A. Griffiths, Karen Yee, Amer M. Zeidan, Aref Al‐Kali, Kim‐Hien Dao, H. Joachim Deeg, Prapti A. Patel, Mitchell Sabloff, Mary‐Margaret Keating, Nancy Zhu, Nashat Gabrail, Salman Fazal, Joseph Maly, Olatoyosi Odenike, Aditi Shastri, Amy E. DeZern, Casey L. O’Connell, Gail J. Roboz, Aram Oganesian, Yong Hao, Harold Keer, Mohammad Azab, Michael R. Savona

    Pubblicazione 2019
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  19. 19
    Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer

    Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer di Ying Chen, Sandra Catalina Camacho, Thomas Silvers, Albiruni R. Abdul Razak, Nashat Gabrail, John F. Gerecitano, Eva Kalir, Elena Pereira, Brad R. Evans, Susan J. Ramus, Fei Huang, Nolan Priedigkeit, Estefanía Rodríguez, Michael Donovan, Faisal M. Khan, Tamara Kalir, Robert Sebra, Andrew Uzilov, Rong Chen, Rileen Sinha, Richard Halpert, Jean-Noël Billaud, Sharon Shacham, Dilara McCauley, Yosef Landesman, Tami Rashal, Michael Kauffman, Mansoor Raza Mirza, Morten Mau‐Sørensen, Peter Dottino, John A. Martignetti

    Pubblicazione 2016
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  20. 20
    Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1

    Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunot... di Benjamin Besse, Enriqueta Felip, Rosario García Campelo, Manuel Cobo, Céline Mascaux, Anne Madroszyk, Federico Cappuzzo, Werner Hilgers, Gianpiero Romano, Fabrice Denis, Santiago Viteri, D. Debieuvre, Domenico Galetta, Editta Baldini, M. Razaq, G. Robinet, Michele Maio, Angelo Delmonte, Benoît Roch, Patrick Masson, Wolfgang Schuette, Alona Zer, Jordi Remón, D Costantini, B. Vasseur, Rafał Dziadziuszko, Giuseppe Giaccone, Milada Zemanová, Benjamin Besse, Clément Bonnet, Jacques Cadranel, C. Chouaïd, Alexis B. Cortot, D. Debieuvre, B. Delclaux, Fabrice Denis, Boris Duchemann, Claude El Kouri, François‐Régis Ferrand, M. Ginoux, Werner Hilgers, Anne Madroszyk, Patrick Masson, Julien Mazières, O. Molinier, Denis Moro‐Sibilot, Éric Pichon, Céline Mascaux, G. Robinet, Benoît Roch, Gérard Zalcman, Gerlinde Schmidtke-Schrezenmeier, Wolfgang Schuette, László Urbán, Maya Gottfried, Hovav Nechushtan, Nir Peled, M. Wollner, Alona Zer, Editta Baldini, Laura Bonanno, Andrea Bonetti, Federico Cappuzzo, Angelo Delmonte, Domenico Galetta, Michele Maio, V. Minotti, Antonio Rea, Gianpiero Romano, Davide Tassinari, Giuseppe Tonini, Rafał Dziadziuszko, Bogusława Karaszewska, Aleksandra Szczésna, Manuel Cobo, Javier de Castro, Enriqueta Felip, M.R. García Campelo, Ainhoa Hernández, Teresa Morán, Mariano Provencio, Santiago Viteri, Abhijit Dasgupta, Nashat Gabrail, Giuseppe Giaccone, A. Harshad, Stephen V. Liu, D. Oubre, Rajiv Panikkar, M. Razaq, Rachel E. Sanborn

    Pubblicazione 2023
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: